Brooke Conti, graduate fellow, Laboratory of Genome Maintenance, The Rockefeller University

Paul Thomas, Ph.D., member, St. Jude faculty, immunology, St. Jude Children’s Research Hospital

Simon Tavaré, Ph.D., professor, Columbia University

Hiten Madhani, M.D., Ph.D., professor, department of biochemistry and biophysics, University of California, San Francisco

Jason Sheltzer, Ph.D., independent fellow, Cold Spring Harbor Laboratory

Eric Greene, Ph.D., professor, department of biochemistry and molecular biophysics, Columbia University

Alfonso Martinez Arias, Ph.D., professor of developmental mechanics, department of genetics, University of Cambridge

Konrad Kording, Ph.D., professor, University of Pennsylvania

James Chen, graduate fellow, Laboratory of Molecular Biophysics, The Rockefeller University

Daniel Fletcher, Ph.D., professor, University of California, Berkeley

Dong Wang, Ph.D., professor, Skaggs School of Pharmacy and Pharmaceutical Science, University of California, San Diego

Melike Lakadamyali, Ph.D., assistant professor of physiology, Perelman School of Medicine, University of Pennsylvania

Kenneth Cadwell, Ph.D., associate professor, department of microbiology, Skirball Institute, New York University School of Medicine

Julie A. Theriot, Ph.D., investigator, Howard Hughes Medical Institute; Benjamin D. Hall Endowed Chair in Basic Life Sciences and professor, department of biology, University of Washington

Nicholas Levinson, Ph.D., professor, department of pharmacology, University of Minnesota

8:00 p.m.: Gordon Fishell, Ph.D., professor of neurobiology, Harvard Medical School; member, Stanley Center for Psychiatric Research at the Broad Institute

John Schoggins, Ph.D., associate professor, The University of Texas Southwestern Medical Center

Jennifer Prescher, Ph.D., professor, chemistry, molecular biology and biochemistry, pharmaceutical sciences, department of chemistry, University of California, Irvine

Michael A. White, Ph.D., vice president and chief scientific officer, Tumor Cell Biology, Pfizer, Oncology Research and Development Group

Andrew Oberst, Ph.D., associate professor, immunology, University of Washington